Sunday, 31 Aug
169
ECP 2014 ·
London
Breakfast and Luncheon Industry Symposia
LS-03
Industry Symposium
13:00 – 14:30 ICC Capital Suite Room 8/11
Pathologists’ role in CD30 detection: the
first steps toward optimal treatment of
haematological malignancies
(Takeda)
Chair:
Wolfram Klapper,
Germany
001
Welcome and introduction
Wolfram Klapper,
Germany
002
The emerging role of CD30
Pier Paolo
Piccaluga, Italy
003
The need for CD30 detection: a haematolo-
gist’s perspective
Peter Borchmann,
Germany
004
Pathologists’ perspective on the challenges
of CD30 detection: an interactive case dis-
cussion
Wolfram Klapper,
Germany
Laurence de
Leval, Switzerland
005
Panel discussion
006
Q&A and closing
Wolfram Klapper,
Germany
LS-04
Industry Symposium
13:00 – 14:30 ICC Capital Suite Room 9/10
Automating Molecular Testing in Lung Can-
cer; Current issues and improving the work-
flow of molecular pathology
(Abbott GmbH)
001
Molecular testing of NSCLC in the real world
Patrick Pauwels,
Belgium
002
Routine testing for ALK gene rearrange-
ments in NSCLC: The Birmingham experi-
ence
Phillipe Taniere,
United Kingdom
003
How can we incorporate more lung biomark-
ers into routine molecular testing?
Fernando Lopez-Rios,
Spain
004
Concluding remarks and Q&A
Patrick Pauwels,
Belgium
